Innovative Preclinical CRO Services with Insightful Support That Advance Your Concept to Reality. Surpass is a trusted partner and contract research organization (CRO) specializing in preclinical services for medical devices, pharmaceuticals, biologics, and combination products. Built on the foundation of a prominent preclinical CRO in the Minneapolis/St.
Paul Area (greater Twin Cities), the team at Surpass has successfully serviced the global Biomedical Community for more than 20 years. Our team has extensive experience conducting translational research in large animal models and human cadavers with specialized expertise in surgical and interventional procedures.
Paul Area (greater Twin Cities), the team at Surpass has successfully serviced the global Biomedical Community for more than 20 years. Our team has extensive experience conducting translational research in large animal models and human cadavers with specialized expertise in surgical and interventional procedures.
Services
Is your novel therapy a medical device, pharmaceutical, biologic, or combination product? We can help with preclinical testing services throughout the innovation and product development cycle. Surpass specializes in studies that involve human cadavers and large animal research models. Our veterinarians and scientists work as an extension of your product development team, offering customized support to meet your project needs.
With increasing pressures on the health care sector, every stakeholder in the medical innovation continuum needs to work in concert. Long gone are the days where engineering, preclinical research, clinical development, regulatory, and other entities operate separately. To stay competitive, the life science industry as a whole needs to be connected in ways that enable us to develop new medical solutions faster, better, and cheaper.
At Surpass, we are not content being just your preclinical research contractor. We are committed to being an active extension of your product development team, a true partner helping you advance life-saving innovations into reality. In order to fulfill this mission our team stays current with trends and challenges facing our clients by being involved in the medical innovation eco system.
At Surpass, we understand that the research we perform on a daily basis has enormous impact on the lives of patients and their families. For translational, preclinical data that advances lifesaving medical innovations into the hands of physicians and patients, choose Surpass. Our goal is to "Surpass" your expectations.
Preclinical Research Leader Surpass CEO Dr. Timothy J Pelura, President and CEO, PhD, is a serial life science entrepreneur and accomplished executive with more than 35 years of experience in pharmaceutical, biotech and medical device industries and has been pivotal in the development of several new drugs spanning numerous therapeutic areas.
Reviews
Be the first to review Surpass.
Write a Review